Evidence map›Paper›PMID 24260469›Full record

ArticlePloS one2013

Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxia.

Gabriele D'Uva, Sara Bertoni, Mattia Lauriola, Sabrina De Carolis, Annalisa Pacilli, Laura D'Anello, Donatella Santini, Mario Taffurelli, Claudio Ceccarelli, Yosef Yarden and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Mechanistic Insight into Long Noncoding RNAs and the Placenta.International journal of molecular sciences · 2017
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor?Oxidative medicine and cellular longevity · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Gabriele D'UvaDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy ; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Sara Bertoni
Mattia Lauriola
Sabrina De Carolis
Annalisa Pacilli
Laura D'Anello
Donatella Santini
Mario Taffurelli
Claudio Ceccarelli
Yosef Yarden
Lorenzo Montanaro
Massimiliano Bonafé
Gianluca Storci
University of Bologna · ITWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia has been long-time acknowledged as major cancer-promoting microenvironment. In such an energy-restrictive condition, post-transcriptional mechanisms gain importance over the energy-expensive gene transcription machinery. Here we show that the onset of hypoxia-induced cancer stem cell features requires the beta-catenin-dependent post-transcriptional up-regulation of CA9 and SNAI2 gene expression. In response to hypoxia, beta-catenin moves from the plasma membrane to the cytoplasm where it binds and stabilizes SNAI2 and CA9 mRNAs, in cooperation with the mRNA stabilizing protein HuR. We also provide evidence that the post-transcriptional activity of cytoplasmic beta-catenin operates under normoxia in basal-like/triple-negative breast cancer cells, where the beta-catenin knockdown suppresses the stem cell phenotype in vitro and tumor growth in vivo. In such cells, we unravel the generalized involvement of the beta-catenin-driven machinery in the stabilization of EGF-induced mRNAs, including the cancer stem cell regulator IL6. Our study highlights the crucial role of post-transcriptional mechanisms in the maintenance/acquisition of cancer stem cell features and suggests that the hindrance of cytoplasmic beta-catenin function may represent an unprecedented strategy for targeting breast cancer stem/basal-like cells.

Indexed as

RNA Processing, Post-Transcriptional3' Untranslated RegionsAnimalsAntigens, Neoplasmbeta CateninBreast NeoplasmsCarbonic Anhydrase IXCarbonic AnhydrasesCell DedifferentiationCell Line, TumorCell NucleusCell ProliferationCell SurvivalDisease Models, AnimalELAV ProteinsEpidermal Growth Factor3' Untranslated RegionsAntigens, Neoplasmbeta CateninCA9 protein, humanCarbonic Anhydrase IXCarbonic AnhydrasesELAV ProteinsEpidermal Growth FactorHypoxia-Inducible Factor 1, alpha SubunitRNA, MessengerSNAI2 protein, humanSnai2 protein, mouseSnail Family Transcription FactorsTranscription Factors

Identifiers

PMID24260469
PMCPMC3829939
OpenAlexW2053879287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.